Search the site

Tate & Lyle PLC announces that the sale of its monosodium glutamate (MSG) production unit in France to Ajinomoto Co., Inc. has now been completed. The signing of a conditional agreement for this disposal was announced on 21 November 2002.

At the Annual General Meeting of Tate & Lyle PLC in London today, Sir David Lees, Chairman, made the following statement on current trading: There has been little overall change in trading conditions or in the outlook since the beginning of June, when I…

In line with its regular practice, Tate & Lyle issues the following trading update prior to meeting with stockbrokers’ analysts and entering its closed period for interim results to 30 September 2003. The interim results will be announced on 6 November…

Tate & Lyle PLC announces today that Richard Delbridge has been appointed as Senior Independent Non-Executive Director and that David Fish and Evert Henkes have been appointed as Non-Executive Directors, all with effect from 1 December 2003. Richard…

Tate & Lyle issues the following trading update. Group profit before tax in the third quarter of the year to 31 March 2004 has been in line with our expectations. At Staley in the US, whilst some of the 2004 sweetener sales contracts have been…

The following information is provided in compliance with paragraph 16.4 of the FSA Listing Rules in respect of the appointments of Dr David Fish and Mr Evert Henkes as Non-Executive Directors of Tate & Lyle PLC on 1 December 2003 (as announced on 5…

Tate & Lyle PLC (“the Company”) announces that, on Friday 1 August 2003, Mr Stuart Strathdee, an executive director of the Company, was allotted 3,522 ordinary shares in the Company on the exercise of a Sharesave option. The option price was 220p. Mr…

Tate & Lyle PLC was informed on 30 September 2003 by the Manager of the Tate & Lyle PLC Corporate Personal Equity Plans (“PEPs”) that on 29 September 2003 purchases of Tate & Lyle PLC Ordinary shares were made at a price of 326.75 pence per share for the…

Tate & Lyle PLC announces a grant of options under the Tate & Lyle 2001 Sharesave Scheme. The date of grant is 5 December 2003 and the option price is 260 pence per share. The options are normally exerciseable during the 6 months following the completion…